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MinireviewAph-1, Pen-2, and Nicastrin
with Presenilin Generate an
Active -Secretase Complex
tivity is a major step in the direction of answering this
question.
The Presenilins (PS) appear to provide the active core
of the protease. Two mammalian homologs, PS1 and
PS2, exist. The PS (50 kDa) span the cellular mem-
Bart De Strooper*
Neuronal Cell Biology and Gene Transfer Laboratory
Center for Human Genetics
K.U. Leuven and Flanders Interuniversitary Institute
for Biotechnology
branes several times (Table 2). Two aspartate residuesVIB4 Leuven
(Asp257 and Asp385) located in transmembrane do-Belgium
mains 6 and 7, respectively (Table 2), are essential for the
catalytic activity of the protease. Although the working
mechanism needs further scrutiny, -Secretase may
-Secretase cleaves the Amyloid Precursor Protein
therefore indeed be considered an aspartyl protease
(APP) in its transmembrane domain, releasing the am- (Wolfe et al., 1999). PS are synthesized as precursor
yloid peptide A. A is the main constituent of the proteins that must become incorporated into a larger
amyloid plaques in the brains of patients suffering from complex for stabilization. The pool that is not incorpo-
Alzheimer’s disease. Several other type I integral mem- rated into these complexes is rapidly degraded by the
brane proteins are also cleaved by this protease. Re- proteasome. The stabilization of PS is accompanied by
cent work indicates that -Secretase is a multiprotein a proteolytic “maturation” cleavage performed by an
complex consisting of Presenilin, Nicastrin, Aph-1, and unknown “presenilinase” (Thinakaran et al., 1996). The
Pen-2 and that all four proteins are necessary for full resulting amino-terminal fragment (NTF, 30 kDa) and
proteolytic activity. Since several paralogs and alter- carboxy-terminal fragment (CTF,20 kDa) each contrib-
natively spliced variants of at least Presenilin and ute separately one aspartyl residue to the catalytic site.
Aph-1 have been identified as well, it is anticipated Both fragments are part of a larger complex. The exact
that -Secretase is not a homogeneous activity. molecular weight of this complex is an issue of debate
-Secretase is an interesting but complex drug target and varies according to the techniques used. The mini-
that challenges classical thinking about proteolytic mal estimate is 200–250 kDa (Kimberly et al., 2003),
processing and intracellular signaling. but 440 kDa (Edbauer et al., 2002) and even larger
complexes have been described. Obviously this issue
needs to be resolved, since it is a decisive piece of
information for estimating the minimal number of sub--Secretase is the proteolytic activity responsible for
units that are needed to constitute the -Secretasethe cleavage of a series of integral membrane proteins
complex.(Table 1), most notoriously the Amyloid Precursor Pro-
Using antibodies against the PS fragments, a secondtein (APP) and Notch. Generally, -Secretase cleaves
member of the complex, called Nicastrin (Nct), was puri-the hydrophobic integral membrane domain of its sub-
fied (Yu et al., 2000). Nct is a glycosylated 130 kDastrates (except for N-cadherin), resulting in the release
integral membrane protein that binds relatively well toof protein fragments at the luminal (extracellular) and at
both the NTF and the CTF of PS. Nct is synthesized asthe cytoplasmic side of the membrane (Annaert and De
a 110 kDa precursor protein that needs PS to leaveStrooper, 2002). In the case of Notch and some other
the endoplasmic reticulum and to reach the cell surface.substrates, the released cytoplasmic domains interact
In PS-deficient cells, the Nct precursor accumulates inwith DNA binding proteins and regulate gene transcrip-
the endoplasmic reticulum. Conversely, suppressingtion, linking -Secretase function to a series of signaling
Nct expression using siRNA results in decreasedprocesses (Table 1). Whether the small fragments that
steady-state levels of PS, indicating that Nct is one ofare shed concomitantly at the luminal side also have
the stabilizing factors of the PS fragments (Table 3;biological functions (e.g., A in case of APP or N in
Edbauer et al., 2002). However, both proteins expressedcase of Notch [Okochi et al., 2002]) remains uncertain.
together do not suffice to increase -Secretase activityIn any event, the A fragment is pathologically important
in most cell lines. Therefore, other proteins are rate lim-since it is the main constituent of the amyloid plaques
iting for the assembly of the active enzyme. Geneticists,in the brain of Alzheimer’s disease patients. For this
studying C. elegans, overcame the final hurdles. Goutte
reason, inhibiting -Secretase is a therapeutic aim, even
and colleagues used a screen for genes that cause an
when doubts are raised concerning the potential side
“anterior pharynx-defective phenotype,” reflecting defi-
effects associated with long-term suppression of this cient glp-1 signaling (glp-1 and lin-12 are the two Notch
activity (Table 1). It is still unknown, at the molecular receptors in C. elegans). They identified two such genes
level, whether -Secretase is a homogeneous or a het- called Aph-1 and Aph-2. Aph-2 is the homolog of mam-
erogeneous activity. If the latter holds true, it is possible malian Nct, while Aph-1 is a novel 30 kDa multimem-
that different complexes preferentially cleave certain brane spanning protein that, similar to PS, is needed for
substrates. This opens the door to novel, more specific the correct subcellular transport of Aph2/Nct to the cell
-Secretase inhibitors. The recent identification of the surface (Goutte et al., 2002). Aph-1 (Pen-1) was also
different molecular components that constitute this ac- identified independently in a screen for Presenilin en-
hancers that cause a glp-1 sterility in a C. elegans strain
partially deficient in PS (Francis et al., 2002). This screen*Correspondence: bart.destrooper@med.kuleuven.ac.be
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Table 1. Substrates of -Secretase (Mammalian)
Substrates Priming Cleavage Fragments and Function
APP, APLP-1, APLP-2 Bace and ADAM A and AICD (gene regulation?)
(constitutively)
Notch 1, 2, 3, and 4 ADAM 17, ADAM 10 (?) N and NICD (gene regulation)
(ligand-induced)
ErbB-4 Metalloproteases B4-ICD (function?)
E-cadherin ? ICD (disassembly of
E-cadherin/catenin complex)
LRP ? ICD (function?)
Nectin-1- ? ICD (function?)
Delta ADAM? ICD (function?)
Jagged ADAM? ICD (function?)
CD44 Metalloproteases CD44, ICD (function?)
yielded in addition the fourth -Secretase partner, and cell-free assays (Kimberly et al., 2003; Takasugi et
al., 2003; Edbauer et al., 2003). Thus, it seems that thePen-2. Pen-2 is a small, hairpin-like membrane protein
with Mr 12 kDa (Table 2). minimal number of components needed for the proteo-
lytic activity of the complex have been identified, Pen-2Aph-1 and Pen-2, like PS and Nct, are essential for
normal Notch (glp-1 and lin-12) signaling in C. elegans and Aph-1 being apparently the long-sought “limiting
cellular factors” controlling PS expression (Thinakaran(Table 3). What is, however, the evidence that they are
also directly involved in the -Secretase activity itself? et al., 1996). Also, the genetic screens in C. elegans
indicate that the core of the complex is now probablyGenetics provide a partial answer. Using constructs that
directly drive expression of the Notch intracellular do- identified: only mutants of these four genes and their
homologs (Table 2) but no other new ones were identi-main, Francis et al. (2002) demonstrated that Aph-1 and
Pen-2 act at or upstream of the release of the Notch fied in the extensive screens by Francis et al. (2002).
In mammalian species the situation is, as usual, moreintracellular domain, like Presenilin does. Downregula-
tion of one of the two new proteins in cells in culture complicated, as several paralogs of the individual proto-
type proteins and a series of alternative spliced formsusing siRNA leads to a decline in -Secretase activity
(Francis et al., 2002; Takasugi et al., 2003; Lee et al., of Aph-1a (Gu et al., 2003) have been identified (Table
2). It should be noticed that, in addition, other proteins2002), comparable to what was demonstrated before
with Nct (Edbauer et al., 2002) and Presenilin (De or lipids could be rate-limiting for the overall activity of
the complex.Strooper et al., 1998) (Table 3). Thus, all four proteins
are needed for cleavage of Notch and APP substrates. From the loss-of-function and overexpression experi-
ments performed in different species (Table 3), it is obvi-Conversely, overexpression of any combination of three
proteins does not increase processing of APP, while ous that the four basic components of the -Secretase
activity influence each other’s stability and maturationoverexpressing the four proteins together results con-
comitantly in the processing and stabilization of PS, the (Gu et al., 2003; Kimberly et al., 2003; Lee et al., 2002;
Luo et al., 2003; Steiner et al., 2002; Takasugi et al.,increased expression of fully glycosylated Nct, and a
clear enhancement of -Secretase activity in cell-based 2003; Edbauer et al., 2003). The effects can be explained
Table 2. The -Secretase Complex Members
Name
(Generic) C. elegans Mammalian Functions
Presenilin HOP-1, SEL-12 PS1, PS2 Catalytic subunit and assembly of
(PSEN in Drosophila) -secretase (glycosylation of Nct,
Pen-2 expression); -catenin
phosphorylation
Nicastrin APH-2 Nct Assembly of -secretase (stabilization
of PS, Pen-2)
Aph-1 APH-1 (PEN-1) Aph1aL and Aph1aS; Assembly of -secretase (stabilization
Aph1b (Aph1c in of PS/Nct)
rodents)




Table 3. Loss- and Gain-of-Function Effects of the Different -Secretase Subunits
Gain of Function
(Overexpression in Cells) Loss of Function (in Cells) Loss of Function (Animals)
PS PS full-length accumulation, Pen-2↓, Nct glycosylation↓, and Notch phenotype (C. elegans,
no stabilization cell surface transport Nct↓ D. melanogaster, M. musculus)
Nct Unglycosylated Nct accumulation PS↓; Pen-2↓ Notch phenotype (C. elegans,
D. melanogaster, M. musculus)
Aph-1 PS full-length accumulation, PS↓, cell surface transport Nct↓ Notch phenotype (C. elegans)
stabilization Nct?
Pen-2 Processing of stabilized PS Accumulation of full-length PS Notch phenotype (C. elegans,
M. musculus)
in different ways: each component could be essential Overall, Aph-1 seems to be least sensitive to changes
in expression of the other proteins, and therefore couldfor one step in the activation of the protease, in which
case none of them needs to be a partner in the final be considered as the scaffold of the complex that binds
PS and Nct. Downregulation of PS affects the stabilityactive complex. However, the available evidence, al-
though still somewhat shaky, suggests the alternative of Pen-2 and the glycosylation of Nct and, vice versa,
downregulation of Nct affects PS stability. This suggestspossibility that the four proteins are subunits of a larger,
relatively stable active complex. Thus, in material pre- that PS and Nct need each other to leave the endoplas-
mic reticulum, probably in concert with Aph-1. Finally,cipitated from cell extracts using antibodies against one
of the subunits, all other subunits are reproducibly de- Pen-2 downregulation results in the accumulation of full-
length PS, but in a stable conformation (Takasugi ettected. Unfortunately, all such experiments made use
of Western blotting to demonstrate the presence of the al., 2003). Thus, Pen-2 seems to be required for the
“Presenilinase” cleavage of PS once PS becomes incor-associated proteins, making it hard to know how specific
and quantitative the observed coprecipitations are. This porated in the complex with Aph-1 and Nct. Further
work is needed to know how Pen-2 controls this “Pre-assay also does not exclude the possibility that a mix of
trimeric complexes is precipitated. Moreover, relatively senilinase” and to understand the kinetics of complex
formation. Also, the subcellular compartments in whichmild detergents were used, and the studies were per-
formed with cells that strongly overexpress the proteins. the different subunits bind each other remain to be in-
vestigated. It seems unlikely that the three proteins as-This raises concerns regarding their correct subcellular
localization before solubilization of the cells and also sociated to PS only function in the global maturation of
the PS protease. Maybe they are also important for theincreases the possibility of nonspecific interactions.
Kimberly et al. (2003) provided an interesting alternative regulation of the activity of the complex and the recogni-
tion of the different -Secretase substrates.for the coimmuneprecipitation experiments using an af-
finity column that retains only the active form of -Secre- Now that several pieces of the puzzle are coming
together, it is important to tackle the question of thetase. Apparently all four components were retained and
coeluted, in support of the hypothesis that they are all molecular mechanism behind the clinical mutations in
PS causing Alzheimer’s disease. As amply shown, thepart of one enzymatic complex. However, here again,
cells strongly overexpressing proteins were used as more than one hundred different missense mutations in
PS1 and PS2 that cause familial Alzheimer’s diseasestarting material. Quantitative analysis of the degree of
purification of the activity and of the coenrichment of (http://molgen-www.uia.ac.be/ADMutations/) all cause
a similar defect, i.e., an increase in the ratio of the A42/the putative -Secretase components was also lacking.
By using this approach in combination with additional A40-species. The A42 peptide is, like A40, generated
by -Secretase cleavage of APP and contains two aminopurification steps, it should be possible in principle to
purify -Secretase to homogeneity from cells that do acids more at its carboxyl terminus. This peptide has
increased aggregation properties and is believed to trig-not overexpress proteins. This will allow researchers to
really evaluate whether the different proteins are stably ger the pathogenic cascade leading to neurodegenera-
tion in Alzheimer’s disease. Since a loss of PS functionassociated and to settle definitively whether any other
factor is needed to generate the active complex. inhibits the generation of both types of A (De Strooper
et al., 1998), it is tempting to consider the mutationsAwaiting this further work, we propose that the working
hypothesis of four proteins acting together in one stable in PS as “gain-” or “change-” of-function mutations.
However, it is unclear how the many different mutationscomplex is reasonable, although not entirely proven.
Further work is also needed to better understand the (indicated by dots in Table 2) scattered over the protein
could all cause such a similar “change” of function. Itmolecular tasks of the different subunits. The loss- and
gain-of-function experiments that were published over is not unlikely that the PS mutations cause subtle de-
fects in the quaternary structure of the-Secretase com-the last months (summarized in Table 3) overall show
that any change in the expression level of one of the plex, which could even result in loss of function toward
other substrates than APP. The fact that human PS1individual components affects the stability, the proteo-
lytic maturation, the glycosylation, or the cell surface is able to rescue PS deficiency in C. elegans and in
mammalian cultured cells, while some PS mutants can-transport of the other subunits (Gu et al., 2003; Kimberly
et al., 2003; Lee et al., 2002; Luo et al., 2003; Steiner et not, would argue for this possibility, at least in regard
to Notch processing (Baumeister et al., 1997; Levitan etal., 2002; Takasugi et al., 2003; Edbauer et al., 2003).
Apparently all four proteins closely regulate each other. al., 1996; Song et al., 1999).
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